Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

Abstract Between 15% and 30% of HIV‐infected subjects fail to increase their CD4+ T‐cell counts despite continuous viral suppression (immunological nonresponders [INRs]). These subjects have a higher morbidity and mortality rate, but there are no effective treatments to reverse this situation so far...

Full description

Bibliographic Details
Main Authors: María Trujillo‐Rodríguez, Pompeyo Viciana, Inmaculada Rivas‐Jeremías, Ana I. Álvarez‐Ríos, Antonio Ruiz‐García, Olga Espinosa‐Ibáñez, Salvador Arias‐Santiago, Juliana Martínez‐Atienza, Rosario Mata, Olga Fernández‐López, Ezequiel Ruiz‐Mateos, Alicia Gutiérrez‐Valencia, Luis F. López‐Cortés
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Stem Cells Translational Medicine
Subjects:
clinical trial
HIV infection
immunological nonresponders
mesenchymal stromal cells
Online Access:https://doi.org/10.1002/sctm.20-0213

Internet

https://doi.org/10.1002/sctm.20-0213

Similar Items